RK

Reena Kumari

Active Director Director DIN 07420662
DIN 07420662 First appointment Feb 2016 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value •••• Premium profile

About Reena Kumari

Data last updated:

Reena Kumari is a Director at Shivcon Pharma Private Limited (since 2016). The company operates in Chemicals. Shivcon Pharma Private Limited reported revenue of ₹11.3 Lakh (FY 2019).

DIN 07420662
Primary Designation Director
Industry Chemicals
First Appointment 18 Feb 2016
Oldest Company Age 10 yrs
Largest company Shivcon Pharma Private Limited · ₹11.3 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shivcon Pharma Private Limited U24230DL2016PTC291361
Director18 Feb 20162016₹11.3 Lakh (FY 2019)Active

Board colleagues of Reena Kumari

NameDINCompanyDesignation
Sanjay Kumar Suman03322404Shivcon Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shivcon Pharma Private Limited
Premium access

Shareholding and investment profile for Reena Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reena Kumari

Reena Kumari currently holds 1 directorship: Shivcon Pharma Private Limited (Director, since 18 Feb 2016, revenue ₹11.3 Lakh (FY 2019)).

Reena Kumari was first appointed on 18 Feb 2016 as Director at Shivcon Pharma Private Limited.

The current boards of Reena Kumari's companies include Sanjay Kumar Suman (Shivcon Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available